ClinicalTrials.gov record
Completed Phase 2 Interventional

Fludarabine and Cyclophosphamide Followed by Peripheral Stem Cell Transplant in Treating Patients With Leukemia or Lymphoma

ClinicalTrials.gov ID: NCT00006252

Public ClinicalTrials.gov record NCT00006252. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 12:40 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Minimal Ablation and Cellular Immune Therapy of Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Low-Grade Non-Hodgkin's Lymphoma, and Mantle Cell Lymphoma With Allogeneic Donor Stem Cells

Study identification

NCT ID
NCT00006252
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cancer and Leukemia Group B
Network
Enrollment
47 participants

Conditions and interventions

Interventions

  • Cyclophosphamide Drug
  • Donor lymphocytes Biological
  • G-CSF Drug
  • PBSC Biological
  • fludarabine phosphate Drug

Drug · Biological

Eligibility (public fields only)

Age range
Up to 69 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2001
Primary completion
Dec 31, 2006
Completion
Sep 30, 2011
Last update posted
Jul 17, 2016

2001 – 2011

United States locations

U.S. sites
19
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
Rebecca and John Moores UCSD Cancer Center La Jolla California 92093-0658
Veterans Affairs Medical Center - San Diego San Diego California 92161
UCSF Comprehensive Cancer Center San Francisco California 94115
Beebe Medical Center Lewes Delaware 19958
CCOP - Christiana Care Health Services Newark Delaware 19713
St. Francis Hospital Wilmington Delaware 19805
Holden Comprehensive Cancer Center at University of Iowa Iowa City Iowa 52242
Union Hospital Cancer Center at Union Hospital Elkton MD Maryland 21921
UMASS Memorial Cancer Center - University Campus Worcester Massachusetts 01655
Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees Voorhees Township New Jersey 08043
Roswell Park Cancer Institute Buffalo New York 14263-0001
Elmhurst Hospital Center Elmhurst New York 11373
Queens Cancer Center of Queens Hospital Jamaica New York 11432
Mount Sinai Medical Center New York New York 10029
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill North Carolina 27599-7295
Wake Forest University Comprehensive Cancer Center Winston-Salem North Carolina 27157-1096
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus Ohio 43210-1240
Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh Pennsylvania 15224-1791
Massey Cancer Center at Virginia Commonwealth University Richmond Virginia 23298-0037

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00006252, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 17, 2016 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00006252 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →